HHLA2 and clear cell renal carcinoma: Also, immune checkpoint HHLA2 was observed to be up-regulated in clear cell renal cell carcinoma and HHLA2 overexpression leads to a remarkable shorter OS and poorer prognosis, implying it could be a potential prognostic biomarker [11].